Neil Cohen - Elspec Director
| ELSPC Stock | ILA 776.10 8.10 1.05% |
Director
Neil Cohen is Director of Elspec since 2007.
| Age | 48 |
| Tenure | 17 years |
| Phone | 972 4 627 2470 |
| Web | https://www.elspec-ltd.com |
Elspec Management Efficiency
The company has return on total asset (ROA) of 0.0359 % which means that it generated a profit of $0.0359 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0782 %, meaning that it generated $0.0782 on every $100 dollars invested by stockholders. Elspec's management efficiency ratios could be used to measure how well Elspec manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Erez Gissin | Arad | 60 | |
| Shmuel Kleiner | Orbit Technologies | 70 | |
| Tova Pinto | Arad | 62 | |
| Serhin Veksler | Arad | 56 | |
| Avraham Zur | Orbit Technologies | 58 | |
| Shmuel Leshem | Arad | 61 | |
| Amos Bendror | Arad | 36 | |
| Aric Cohen | Arad | 45 | |
| Naama Zeldis | Orbit Technologies | 56 | |
| Ronny Barnir | Arad | 57 | |
| Ephraim Abramson | Arad | 69 | |
| Uri Meital | Arad | 62 | |
| Daniel Vaknin | Arad | 60 | |
| Ron BenHaim | Orbit Technologies | 49 | |
| Shacham Mittler | Arad | 44 | |
| Gillon Beck | Orbit Technologies | 56 | |
| Yoseph Dauber | Orbit Technologies | 79 | |
| Ronit Lavi | Al Bad Massuot Yitzhak | 56 | |
| Yael Adler | Orbit Technologies | 45 | |
Management Performance
| Return On Equity | 0.0782 | |||
| Return On Asset | 0.0359 |
Elspec Leadership Team
Elected by the shareholders, the Elspec's board of directors comprises two types of representatives: Elspec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elspec. The board's role is to monitor Elspec's management team and ensure that shareholders' interests are well served. Elspec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elspec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mordechai Mesholam, Chairman of the Board | ||
| Neil Cohen, Director | ||
| Eitan Livneh, External Director | ||
| Nadav Harary, Development Manager | ||
| Oren Harari, Deputy CTO | ||
| Robert Seagrave, Chief USA | ||
| Rui Almeida, Chief Executive Officer of the Company’s Subsidiary | ||
| Sagit Sabag, External Director | ||
| Yoram Harary, Chief Executive Officer, Director | ||
| Roy Almeida, CEO Subsidiary | ||
| Ron Harary, Chief Financial Officer, Director | ||
| Oren Harary, Chief Technology Officer | ||
| Ronit Harary, Chief Officer | ||
| Liat Benyamini, Director | ||
| Daisy Gerson, CEO Subsidiary | ||
| Asaf Laifer, Head of Measuring Unit |
Elspec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elspec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0782 | |||
| Return On Asset | 0.0359 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 53.12 M | |||
| Shares Outstanding | 19.46 M | |||
| Shares Owned By Insiders | 54.86 % | |||
| Shares Owned By Institutions | 11.30 % | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 0.88 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Elspec Stock Analysis
When running Elspec's price analysis, check to measure Elspec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elspec is operating at the current time. Most of Elspec's value examination focuses on studying past and present price action to predict the probability of Elspec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elspec's price. Additionally, you may evaluate how the addition of Elspec to your portfolios can decrease your overall portfolio volatility.